Search

Search Constraints

You searched for: Subject 616.37005

Search Results

1912. Utility of Assessing the Number of Mutated KRAS, CDKN2A, TP53, and SMAD4 Genes Using a Targeted Deep Sequencing Assay as a Prognostic Biomarker for Pancreatic Cancer. Issue 3 (March 2017)

1915. Utility of DNA Profiling From Main Pancreatic Duct Fluid by Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography to Screen for Malignant Potential. Issue 5 (May 2020)

1918. Vagotomy and Splenectomy Reduce Insulin Secretion and Interleukin-1β. Issue 4 (April 2021)

1919. Validation of a Nomogram for Predicting the Probability of Carcinoma in Patients With Intraductal Papillary Mucinous Neoplasm in 180 Pancreatic Resection Patients at 3 High-Volume Centers. Issue 3 (April 2015)

1920. Validation of a Nomogram for Predicting the Probability of Carcinoma in Patients With Intraductal Papillary Mucinous Neoplasm in 180 Pancreatic Resection Patients at 3 High-Volume Centers. Issue 3 (April 2015)